How AI targets the bad problem of drug development

A new drug usually takes more than a decade to develop, at a cost of nearly $3 billion. That’s because about 90% of experimental drugs fail in various stages of chemical engineering, or during animal or human testing. So drug manufacturers and investors are spending billions of dollars to augment the search for new treatments using artificial intelligence. Scientists are seeking to discover breakthrough drugs by rapidly identifying new compounds and modeling the complex mechanisms in medicine. How AI targets the bad problem of drug development


Inter Reviewed is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – The content will be deleted within 24 hours.

Related Articles

Back to top button